Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Endemic and emerging arboviral diseases of livestock in Nigeria: a review.

Oluwayelu D, Adebiyi A, Tomori O.

Parasit Vectors. 2018 Jun 7;11(1):337. doi: 10.1186/s13071-018-2911-8. Review.

2.

Building a global atlas of zoonotic viruses.

Carroll D, Watson B, Togami E, Daszak P, Mazet JA, Chrisman CJ, Rubin EM, Wolfe N, Morel CM, Gao GF, Burci GL, Fukuda K, Auewarakul P, Tomori O.

Bull World Health Organ. 2018 Apr 1;96(4):292-294. doi: 10.2471/BLT.17.205005. Epub 2018 Mar 5. No abstract available.

3.

The Global Virome Project.

Carroll D, Daszak P, Wolfe ND, Gao GF, Morel CM, Morzaria S, Pablos-Méndez A, Tomori O, Mazet JAK.

Science. 2018 Feb 23;359(6378):872-874. doi: 10.1126/science.aap7463. No abstract available.

PMID:
29472471
4.

Biosafety level-2 laboratory diagnosis of Zaire Ebola virus disease imported from Liberia to Nigeria.

Salu OB, James AB, Oke BO, Orenolu MR, Anyanwu RA, Abdullah MA, Happi C, Idris J, Abdus-Salam IA, Nasidi AS, Ogunsola FT, Tomori O, Omilabu SA.

Afr J Lab Med. 2016 Oct 17;5(1):468. doi: 10.4102/ajlm.v5i1.468. eCollection 2016.

5.

The next WHO Director-General's highest priority: a Global Treaty on the Human Right to Health.

Gostin LO, Friedman EA, Buss P, Chowdhury M, Grover A, Heywood M, Kanchanachitra C, Leung G, Mackay J, Matsoso P, Møgedal S, Mukherjee JS, Omaswa F, Phumaphi J, Reddy KS, Periago MR, Thomas J, Tomori O, Were M, Zewdie D.

Lancet Glob Health. 2016 Dec;4(12):e890-e892. doi: 10.1016/S2214-109X(16)30219-4. Epub 2016 Oct 13. No abstract available.

6.

Ebola Virus Epidemiology and Evolution in Nigeria.

Folarin OA, Ehichioya D, Schaffner SF, Winnicki SM, Wohl S, Eromon P, West KL, Gladden-Young A, Oyejide NE, Matranga CB, Deme AB, James A, Tomkins-Tinch C, Onyewurunwa K, Ladner JT, Palacios G, Nosamiefan I, Andersen KG, Omilabu S, Park DJ, Yozwiak NL, Nasidi A, Garry RF, Tomori O, Sabeti PC, Happi CT.

J Infect Dis. 2016 Oct 15;214(suppl 3):S102-S109. Epub 2016 Jul 4.

7.

Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola.

Gostin LO, Tomori O, Wibulpolprasert S, Jha AK, Frenk J, Moon S, Phumaphi J, Piot P, Stocking B, Dzau VJ, Leung GM.

PLoS Med. 2016 May 19;13(5):e1002042. doi: 10.1371/journal.pmed.1002042. eCollection 2016 May.

8.

Global incidence of serogroup B invasive meningococcal disease: a systematic review.

Sridhar S, Greenwood B, Head C, Plotkin SA, Sáfadi MA, Saha S, Taha MK, Tomori O, Gessner BD.

Lancet Infect Dis. 2015 Nov;15(11):1334-46. doi: 10.1016/S1473-3099(15)00217-0. Epub 2015 Oct 6. Review.

PMID:
26453240
9.

Will Africa's future epidemic ride on forgotten lessons from the Ebola epidemic?

Tomori O.

BMC Med. 2015 May 14;13:116. doi: 10.1186/s12916-015-0359-7.

10.

Randomised controlled trials for Ebola: practical and ethical issues.

Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, Delfraissy JF, Heymann D, Horby P, Kaleebu P, Tamfum JJ, Olliaro P, Piot P, Tejan-Cole A, Tomori O, Toure A, Torreele E, Whitehead J.

Lancet. 2014 Oct 18;384(9952):1423-4. doi: 10.1016/S0140-6736(14)61734-7. Epub 2014 Oct 13. No abstract available.

11.

Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014.

Fasina FO, Shittu A, Lazarus D, Tomori O, Simonsen L, Viboud C, Chowell G.

Euro Surveill. 2014 Oct 9;19(40):20920. Erratum in: Euro Surveill. 2015;20(17). pii: 21109. Euro Surveill. 2015;20(17). pii: 21107.

12.

Progress toward laboratory containment of poliovirus after polio eradication.

Wolff C, Roesel S, Lipskaya G, Landaverde M, Humayun A, Withana N, Ramamurty N, Tomori O, Okiror SO, Salla M, Dowdle W.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S454-8. doi: 10.1093/infdis/jit821.

PMID:
25316867
13.

Ebola in an unprepared Africa.

Tomori O.

BMJ. 2014 Sep 15;349:g5597. doi: 10.1136/bmj.g5597. No abstract available.

PMID:
25224647
14.

Variola virus archives: a new century, a new approach.

Jahrling PB, Tomori O.

Lancet. 2014 May 3;383(9928):1525-6. doi: 10.1016/S0140-6736(14)60693-0. No abstract available.

PMID:
24792843
15.

Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, Pate MA, Abanida EA, Gasasira A, Iber J, Chen Q, Vincent A, Chenoweth P, Henderson E, Wannemuehler K, Naeem A, Umami RN, Nishimura Y, Shimizu H, Baba M, Adeniji A, Williams AJ, Kilpatrick DR, Oberste MS, Wassilak SG, Tomori O, Pallansch MA, Kew O.

J Virol. 2013 May;87(9):4907-22. doi: 10.1128/JVI.02954-12. Epub 2013 Feb 13.

16.

From smallpox eradication to the future of global health: innovations, application and lessons for future eradication and control initiatives.

Tomori O.

Vaccine. 2011 Dec 30;29 Suppl 4:D145-8. doi: 10.1016/j.vaccine.2011.09.003. Epub 2011 Dec 18. Review.

PMID:
22185830
17.

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.

Jentes ES, Poumerol G, Gershman MD, Hill DR, Lemarchand J, Lewis RF, Staples JE, Tomori O, Wilder-Smith A, Monath TP; Informal WHO Working Group on Geographic Risk for Yellow Fever.

Lancet Infect Dis. 2011 Aug;11(8):622-32. doi: 10.1016/S1473-3099(11)70147-5. Review. Erratum in: Lancet Infect Dis. 2012 Feb;12(2):98.

PMID:
21798462
18.

Yellow fever: the recurring plague.

Tomori O.

Crit Rev Clin Lab Sci. 2004;41(4):391-427. Review.

PMID:
15487593
19.

Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Bausch DG, Borchert M, Grein T, Roth C, Swanepoel R, Libande ML, Talarmin A, Bertherat E, Muyembe-Tamfum JJ, Tugume B, Colebunders R, Kondé KM, Pirad P, Olinda LL, Rodier GR, Campbell P, Tomori O, Ksiazek TG, Rollin PE.

Emerg Infect Dis. 2003 Dec;9(12):1531-7.

20.

Polio and other enterovirus isolation by region in Ethiopia, 2000-2002.

Mentaye BB, Zelalem M, Asha A, Tiruneh Y, Afework A, Tedela M, Bezuneh T, Senbet AG, Oyewole F, Abebe A, Woldemichael T, Tomori O.

Jpn J Infect Dis. 2003 Jun;56(3):119-21. No abstract available.

21.

Eradication of poliomyelitis in Ethiopia: virological and acute flaccid paralysis surveillance.

Mentaye BB, Tomori O, Femi O, Senbet AG, Woldemichael T.

Jpn J Infect Dis. 2002 Jun;55(3):95-7. No abstract available.

PMID:
12195053
22.

Yellow fever in Africa: public health impact and prospects for control in the 21st century.

Tomori O.

Biomedica. 2002 Jun;22(2):178-210. Review. English, Spanish.

PMID:
12152484
23.

Progress towards polio eradication: an African perspective.

Schoub BD, Gumede HN, Besselaar TG, Blackbum NK, Webb EM, Tomori O, Otten M.

Dev Biol (Basel). 2001;105:9-19.

PMID:
11763342
24.

Human immunodeficiency virus types 1 and 2 infection in some rural areas of Nigeria.

Odaibo GN, Olaleyé OD, Tomori O.

Rom J Virol. 1998 Jan-Dec;49(1-4):89-95.

PMID:
10892430
25.

Impact of yellow fever on the developing world.

Tomori O.

Adv Virus Res. 1999;53:5-34. Review.

PMID:
10582093
26.

Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995.

Tomori O, Bertolli J, Rollin PE, Fleerackers Y, Guimard Y, De Roo A, Feldmann H, Burt F, Swanepoel R, Killian S, Khan AS, Tshioko K, Bwaka M, Ndambe R, Peters CJ, Ksiazek TG.

J Infect Dis. 1999 Feb;179 Suppl 1:S98-101.

PMID:
9988171
27.

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, Rollin PE, Sanchez A, Zaki SR, Swanepoel R, Tomori O, Nichol ST, Peters CJ, Muyembe-Tamfum JJ, Ksiazek TG.

J Infect Dis. 1999 Feb;179 Suppl 1:S76-86.

PMID:
9988168
28.

Does neuroanatomy predict ECT response?

Dequardo JR, Tomori O, Brunberg JA, Tandon R.

Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov;21(8):1339-52.

PMID:
9460096
29.

A survey for antibodies to Lassa virus among health workers in Nigeria.

Bajani MD, Tomori O, Rollin PE, Harry TO, Bukbuk ND, Wilson L, Childs JE, Peters CJ, Ksiazek TG.

Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):379-81.

PMID:
9373625
30.

Overview of poliomyelitis in the African Region and current regional plan of action.

Okwo-Bele JM, Lobanov A, Biellik RJ, Birmingham ME, Pierre L, Tomori O, Barakamfitiye D.

J Infect Dis. 1997 Feb;175 Suppl 1:S10-5. Review.

PMID:
9203685
32.

Yellow fever: a decade of reemergence.

Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K.

JAMA. 1996 Oct 9;276(14):1157-62. Review.

PMID:
8827969
33.

Rift Valley fever in Nigeria: infections in domestic animals.

Olaleye OD, Tomori O, Schmitz H.

Rev Sci Tech. 1996 Sep;15(3):937-46.

PMID:
9025143
34.

Rift Valley fever in Nigeria: infections in humans.

Olaleye OD, Tomori O, Ladipo MA, Schmitz H.

Rev Sci Tech. 1996 Sep;15(3):923-35.

PMID:
9025142
35.

Clinical and pathological features of Nigerian equine encephalitis.

Adeyefa CA, Tomori O, Akpavie SO, Awoseyi OA.

Vet Rec. 1996 Apr 6;138(14):323-6.

PMID:
8730673
36.

Circulation of poliovirus among risk groups in Ibadan, Nigeria.

Adu FD, Odemuyiwa SO, Tomori O.

Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):126-7.

PMID:
8761568
37.

Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley Fever virus.

Olaleye OD, Tomori O, Fajimi JL, Schmitz H.

Rev Elev Med Vet Pays Trop. 1996;49(1):6-16.

PMID:
8881413
38.

Clinico-epidemiological patterns of HIV infection in STD patients in Ibadan.

Ekweozor CC, Olaleye OD, Tomori O, Saliu I, Essien EM, Bakare RA, Oni AA, Oyewo OO, Okesola AO, Onyemenem TN, et al.

Afr J Med Med Sci. 1995 Dec;24(4):321-7.

PMID:
8886145
39.

Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.

Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB.

BMJ. 1995 Sep 30;311(7009):857-9.

40.

Sexually transmitted diseases in Ibadan in the 1990's: HIV infection--an additional dimension.

Ekweozor CC, Olaleye OD, Tomori O, Saliu I, Essien EM.

Afr J Med Med Sci. 1994 Dec;23(4):363-7.

PMID:
7653404
41.

Yellow fever vaccination and pregnancy: a four-year prospective study.

Nasidi A, Monath TP, Vandenberg J, Tomori O, Calisher CH, Hurtgen X, Munube GR, Sorungbe AO, Okafor GC, Wali S.

Trans R Soc Trop Med Hyg. 1993 May-Jun;87(3):337-9.

PMID:
8236412
42.

Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.

Adu FD, Adeniji JA, Tomori O, Adelasoye A.

Rom J Virol. 1993 Jan-Jun;44(1-2):3-7.

PMID:
9702244
43.
44.

Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.

Adu FD, Adeniji JA, Tomori O, Adelasoye A.

Rev Roum Virol. 1993 Jan-Jun;44(1-2):3-7.

PMID:
8043476
45.

Electron microscopic identification of Zinga virus as a strain of Rift Valley fever virus.

Olaleye OD, Baigent CL, Mueller G, Tomori O, Schmitz H.

Res Virol. 1992 May-Jun;143(3):215-8.

PMID:
1518967
46.

Evaluation of measles vaccination programme conducted in two separate health centres.

Onoja AL, Adu FD, Tomori O.

Vaccine. 1992;10(1):49-52.

PMID:
1539460
47.

Low seroconversion rates to measles vaccine among children in Nigeria.

Adu FD, Akinwolere OA, Tomori O, Uche LN.

Bull World Health Organ. 1992;70(4):457-60.

48.

Detection of rabies virus antibodies in fruit bats (Eidolon helvum) from Nigeria.

Aghomo HO, Ako-Nai AK, Oduye OO, Tomori O, Rupprecht CE.

J Wildl Dis. 1990 Apr;26(2):258-61.

PMID:
2187101
49.

Detection of Mokola virus neutralising antibodies in Nigerian dogs.

Aghomo HO, Tomori O, Oduye OO, Rupprecht CE.

Res Vet Sci. 1990 Mar;48(2):264.

PMID:
2333438
50.

Inactivated oil emulsion vaccines from selected clones of Newcastle disease virus.

Adu FD, Oyejide A, Tomori O.

Vet Q. 1989 Jul;11(3):190-2.

PMID:
2781713

Supplemental Content

Loading ...
Support Center